Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

British Journal of Cancer

Volumn 79, Issue 11-12, 1999, Pages 1828-1835

  Forsyth, P A ^a,b,c   Wong, H ^b   Laing, T D ^b   Rewcastle, N B ^a   Morris, D G ^a,b,c   Muzik, H ^a,b,c   Leco, K J ^b   Johnston, R N ^b   Brasher, P M A ^a   Sutherland, G ^d   Edwards, D R ^b  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

^d Tom Baker Cancer Center ^*

Author keywords

Gelatinase A; Gelatinase B; Gliomas; In situ hybridization; MT1 MMP

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MESSENGER RNA;

ARTICLE; GLIOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

EID: 0033038483     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6990291     Document Type: Article

References (54)

1. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH and Banda MJ (1990) Expression of metalloproteinase and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329
2. Aznavoorian S, Murphy AN, Stetler-Stevenson WG and Liotta LA (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-1383
3. Azzam HS, Arand G, Lippman ME and Thompson WE (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758-1754
4. Bendeck MP, Irvin C and Reidy MA (1996) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78: 38-43
5. Bernhard EJ, Gruber SB and Muschel RJ (1994) Direct evidence linking expression of matrix metalloproteinase 9 (92 kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat cells. Proc Natl Acad Sci USA 91: 4293-4297
6. Brown PD, Bloxidge RE, Stuart NS, Gatter KC and Carmichael J (1993) Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma. J Natl Cancer Inst 85: 574-579
7. Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC and Giangaspero F (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159-169
8. Butler GS, Will H, Atkinson SJ and Murphy G (1997) Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 244: 653-657
9. Cornelius LA, Nehring LC, Roby JD, Parks WC and Welgus HG (1995) Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol 105: 170-176
10. Costello PC, Del Maestro RF and Stetler-Stevenson WG (1994) Gelatinase A expression in human malignant gliomas. Ann NY Acad Sci 732: 450-452
11. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F (1993) Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369
12. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ and Lim MS (1996) The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obesity 20: S9-S15
13. Foda HD, George S, Conner C, Drews M, Tompkins DC and Zucker S (1996) Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase Lab Invest 74: 539-545
14. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186
15. Forsyth PA, Dickinson-Laing T, Gibson AW, Rewcastle NB, Brasher P, Sutherland G, Johnston RN and Edwards DR (1998) High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol 36: 21-29
16. Giese A and Westphal M (1996) Glioma invasion in the central nervous system. Neurosurgery 39: 235-252
17. Haddad SF, Moore SA, Schelper RL and Goeken JA (1992) Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 51: 488-492
18. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
19. Hanemaaijer R, Koolwijk, Le Clerc QL, De Vree WJA and Van Hinsbergb VWM (1993) Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor α, interleukin 1 and phorbol ester. Biochem J 296: 803-809
20. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH (1996) Expression of most MMP family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273-282
21. Hirschi KK and D'Amore P (1996) Pericytes in the microvasculature. Cardiovasc Res 32: 687-698
22. Johnson MD, Kim HR, Chesler L, Tsao Wu-G, Bouck N and Polverini PJ (1994) Inhibition of angiogenesis by TIMP. J Cell Physiol 160: 194-202
23. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA and Kispert DB (1987) Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clinic Proc 62: 450-459
24. Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA and Edwards DR (1997) Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Letts 401: 213-217
25. Lewalle JM, Munaut C, Pichot B, Cataldo D, Baramova E and Foidart JM (1995) Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol 165: 475-483
26. Mignatti P and Rifkin DB (1993) Biology and chemistry of proteneises in tumor invasion. Physiol Rev 73: 161-185
27. Murphy G and Knauper V (1997) Relating matrix metalloproteinase structure to function: Why the 'Hemopexin' domain? Matrix Biol 15: 511-518
28. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T and Okada Y (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77
29. Nakagawa T, Kubota T, Kabuto M, Fujimoto N and Okada Y (1996) Secretion of matrix metalloproteinases-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. J Neurooncol 28: 13-24
30. Nakano A, Tani E, Miyazaki K, Yamamoto Y and Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307
31. Nakano A, Tani E, Miyazaki K, Furuyama J and Matsumoto T (1993) Expressions of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999-1003
32. Pendas AM, Knauper V, Puente XS, Llano E, Mattei M-G, Apte S, Murphy G and Lopez-Otin C (1997) Identification and characterization of a novel human matrix metalloproteinase and unique structural characteristics, chromosomal location and tissue distribution. J Biol Chem 272: 4281-4286
33. Poulsom R, Hanby AM, Pignatelli M, Jeffrey RE, Longcroft JM, Rogers L and Stamp GWH (1993) Expression of gelatinase-A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46: 429-436
34. Puente XS, Pendas AM, Llano E, Velasco, G and Lopez-Otin C (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56: 944-949
35. Pyke C, Ralfkiaer E, Tryggvason K and Dano K (1993) Messenger RNA for two types of type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359-365
36. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA and Sawaya R (1993) Elevated levels of Mr 92000 type IV collagenase in human brain tumors. Cancer Rev 53: 2208-2211
37. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Stetler-Stevenson WG, Rao VH, Fuller GN, Liotta LA, Nicolson GL and Sawaya RE (1996) Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14: 12-18
38. Rosenthal RA, Moses MA, Shintani Y, Megyesi JF, Langer R and Folkman J (1994) Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium. J Cell Biochem 56: 97-105
39. Rutka JT, Matsuzawa K, Hubbard SL et al (1995) Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Oncol 6: 877-884
40. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65
41. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL and Rao JS (1996) Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14: 35-42
42. Saxena A, Robertson JT and Kufta C (1995) Increased expression of gelatinase A and TIMP-2 in primary human glioblastomas. Int J Oncol 7: 469-473
43. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi C, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, Quigley JP and Kleinman HK (1993) Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156: 235-246
44. Taraboletti G, Garofalo A, Beloui D, Drudis T, Borsotti P, Scanziani E, Brown PD and Giavazzi R (1995) Inhibition of angiogenesis and murine hemangioma growth by Batimasatat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 87: 293-298
45. Thorgeirsson UP, Yoshiji H, Sinha CC and Gomez DE (1996) Breast cancer; tumor neovasculature and the effect of TIMP-1 on angiogenesis. In vivo 10: 137-144
46. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M and Okada Y (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57: 2055-2060
47. Uhm JH, Dooley NP, Villemure J-G and Yong VW (1996) Glioma invasion in vitro: regulation by matrix metalloproteinase-2 and protein kinase C. Clin Exp Metastasis 14:421-433
48. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A and Kossakowska AE (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66: 1188-1194
49. Wesseling P, Schlingemann RO, Rietveld FJR, Link M, Burger PC and Ruiter DJ (1995) Early and extensive contribution of pericyte/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immunolight and immuno-electron microscopic study. J Neuropathol Exp Neurol 54: 304-310
50. Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 5: 2145-2154
51. Wong H, Anderson WD, Cheng T and Riabowol KT (1994) Monitoring mRNA expression by polymerase chain reaction: the 'primer-dropping' method. Anal Biochem 223: 251-258
52. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL and Rao JS (1996) Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase-A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56: 384-392
53. Yong VW, Krekowski CA, Forsyth PA, Bell R and Edwards D (1998) Matrix Metalloproteinases and diseases of the CNS. Trends Neurosci 21: 75-80
54. Zucker S, Cponner C, DiMassmo BI, Ende H, Drews M, Seiki M and Bahou WF (1995) Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 270: 23730-23738